Purple Biotech (PPBT) Interest Coverage Ratio (2014 - 2026)
Purple Biotech (PPBT) reported Interest Coverage Ratio of 72.61 for Q1 2026, up 80.76% year-over-year from 40.17 in Q1 2025, and up 80.76% on a QoQ basis from 40.17 in Q1 2025.
Purple Biotech (PPBT) has 2 years of Interest Coverage Ratio data on file, last reported at 72.61 in Q1 2026.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -129.79 |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 3.58 |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -258.33 |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | 11.50 |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 49.84 |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 3.88 |
| 10 | Purple Biotech | 3.58 Bn | 3.57 Bn | - | 72.61 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 72.61 |
| Dec 31, 2025 | 109.56 |
| Sep 30, 2025 | 273.40 |
| Jun 30, 2025 | -61.80 |
| Mar 31, 2025 | 40.17 |
| Dec 31, 2024 | -14.72 |
| Sep 30, 2024 | 4.17 |
| Jun 30, 2024 | 144.08 |
| Mar 31, 2024 | 262.71 |
| Dec 31, 2023 | 3.00 |
| Sep 30, 2023 | 359.19 |
| Jun 30, 2023 | 34.70 |
| Mar 31, 2023 | 86.81 |
| Dec 31, 2022 | 366.72 |
| Sep 30, 2022 | 317.56 |
| Jun 30, 2022 | 70.39 |
| Mar 31, 2022 | 178.80 |
| Dec 31, 2021 | 68.68 |
| Sep 30, 2021 | 144.86 |
| Jun 30, 2021 | 35.51 |
| Mar 31, 2021 | 326.55 |
| Dec 31, 2020 | 179.83 |
| Dec 31, 2019 | 49.22 |
| Dec 31, 2018 | 17.63 |
| Dec 31, 2017 | 310.37 |
| Dec 31, 2015 | -22.36 |
| Sep 30, 2015 | 3.37 |
| Dec 31, 2014 | 2.53 |
| Sep 30, 2014 | 9.03 |